D. McCarley

发表

Bladder-sparing approach in the treatment of invasive bladder cancer.

J. Parsons, D. Oblon, Z. Wajsman, 1990, Seminars in urology.

Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up.

J. Parsons, Z. Wajsman, D. McCarley, 1995, Urology.

A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial.

A. Bartolucci, M. Stagg, J. Moore, 1994, Leukemia.

High‐grade B‐cell lymphoma presenting as polyserosal disease. Diagnosis by flow cytometry

Tarique Siddiqui, R. Braylan, T. Siddiqui, 1989, Cancer.

Diagnostic and therapeutic utility of monoclonal antibodies in urologic oncology.

R. Weiner, D. McCarley, 1989, Seminars in surgical oncology.

Comparative Evaluation of Enalapril and Hydrochlorothiazide in Elderly Patients with Mild to Moderate Hypertension

G. Stein, J. Gums, L. Lopez, 1988, Drug intelligence & clinical pharmacy.

Antibody-dependent cell-mediated cytotoxicity of cryopreserved human monocytes.

R. Weiner, D. McCarley, V. O. Shah, 1984, Cryobiology.

Five-Year Results of a Phase II Trial of Hyperfractionated Radiotherapy and Concurrent Daily Cisplatin Chemotherapy for Stage III Non-Small-Cell Lung Cancer

R. Zlotecki, E. Harman, D. Knauf, 2005, American journal of clinical oncology.

Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.

R. Zlotecki, S. Kamath, D. McCarley, 1998, Radiation oncology investigations.

Topotecan-induced topoisomerase IIα expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment

M. Mainwaring, Sifen chen, D. McCarley, 2002, Cancer Chemotherapy and Pharmacology.

New uses for old vitamins. The treatment of myelodysplastic disorders.

D. McCarley, 1993, The Medical clinics of North America.

The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.

H. Cherwinski, R. Schatzman, J. Ransom, 1995, The Journal of pharmacology and experimental therapeutics.

Arteriovenous malformation of the mandible: report of case.

D. McCarley, E. H. Hall, 1988, Journal of the American Dental Association.

Purified human monocyte subsets as effector cells in antibody-dependent cellular cytotoxicity (ADCC).

R. Weiner, D. McCarley, V. O. Shah, 1983, Journal of Immunology.

1034 Preoperative radiotherapy for resectable rectal cancer: Improved local control is prognostic for distant metastasis occurrence and survival

W. Mendenhall, E. Copeland, R. Zlotecki, 1996 .